LAS VEGAS, March 29, 2010 (GLOBE NEWSWIRE) -- Gamma Pharmaceuticals, Inc. (Pink Sheets:GMPM) ("Gamma" or the "Company") through its joint venture company, Holyfield Gamma Choice LLC, accepts the first purchase order for "Holyfield's Choice Water" from the Company's distribution partner. One day after issuing the purchase order to Gamma, the Company's distribution partner received purchase orders from clients for product placement in 1,500 retail outlets, 250 restaurants and approximately 2,000 vending machines. Gamma expects to book the revenue from this first transaction in the quarter ending June 30, 2010.
Peter Cunningham, a Holyfield Gamma Choice LLC management board member, stated, "The pace and scale of our capability to implement product roll-out is noteworthy. The joint venture with Holyfield International was announced March 1, 2010; the contract with our distribution partner was announced on March 3rd; on March 24th, Holyfield Gamma Choice LLC announced the roll-out of "The Holyfield Challenge" on college campuses; and, today, we are announcing placement of Holyfield's Choice products across three major commercial channels."
Dwayne Corbitt, a Holyfield Gamma Choice LLC management board member, added, "Holyfield's Choice Water is an Alkaline Water. Scientific studies conclude that Alkaline Water can offset the effects on the body's normal pH caused by exercise, diet, the environment, amongst other causes. Evander Holyfield has been drinking Alkaline Waters as part of his fitness and healthy lifestyle regime for several years. Holyfield Gamma Choice LLC brings Alkaline Water to the public for daily consumption through retail, restaurant and vending channels at competitive prices."
Holyfield Gamma Choice LLC is formulating and marketing an innovative line of vitamins and nutritional products utilizing Mr. Holyfield's expertise in nutrition and physical training and Gamma's formulation and marketing know-how. Holyfield Gamma Choice LLC products are labeled Holyfield Choice. Holyfield Gamma Choice LLC is closely integrated with Gamma's existing corporate infrastructure and distribution channels, and currently has four product lines and seven SKUs, with plans for expansion. Under the terms of the venture, Gamma will consolidate the joint venture's performance into Gamma's financials.
About Gamma Pharmaceuticals, Inc.
Gamma Pharmaceuticals, Inc. (www.gammapharma.com/">www.gammapharma.com) is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally. Gamma's core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in the United States and Greater China. Branded nutritional supplements are sold under the trademarks Brilliant Choice™ children's nutritional supplements featuring the call to action "Mom you've made a brilliant choice for your children's nutrition;" SAVVY™ adult nutritional supplements featuring the call to action, "Be SAVVY Stay Healthy;" and Jugular Energy Products™ and high performance supplements featuring the call to action, "Go for the Jugular™." Gamma's customer focus is on selling products in the Lifestyle of Health & Sustainability ("LOHAS") marketplace and in the Energy Supplement Market. A series of innovative marketing programs supports Gamma's product sales and retail partners.
At present, Gamma manufactures in North America, and distributes in the United States and China. Gamma's products utilize proprietary "Gel Delivery Technology®" to create innovative gel product forms that give consumers a more pleasant experience. Gel Delivery Technology® characteristics include rapid absorption, convenience and taste great. Market categories Gamma targets are growing as rapidly as 60% per year. Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well Being, Menopause Symptoms and Personal Care Products. Gamma also develops and manufactures house brands for major retailers. At this time, Gamma has a total of 36 SKUs and holds licenses for 9 SKUs in China.
Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company's stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.